Patent · US Active

Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides

US10159707B2 · kind B2 · utility

0Cited by
45References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2017
Grant dateDec 25, 2018
Priority date—
Expiry dateMay 4, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16071
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.